Originally published by our sister publication Pharmacy Practice News
Prior authorizations (PAs) remain an entrenched tool for payors to flex their muscles in their attempts to control spending.
Although predominantly used by commercial payors, both Medicare and the various Medicaid programs also want a say in what treatment is being chosen. The logistics of PAs are mind-boggling, consuming a phenomenal amount of resources both within the healthcare setting and in the ambulatory